ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,389Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 113

$356K Total Retail Price of All Prescriptions

Rank: 63 out of 113

395 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 395 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,194 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LISINOPRIL 426 386 1 3
LEVOTHYROXINE SODIUM 408 325 2 1
SIMVASTATIN 316 295 3 2
AMLODIPINE BESYLATE 286 260 4 4
POTASSIUM CHLORIDE 260 209 5 12
FUROSEMIDE 245 219 6 6
OMEPRAZOLE 215 204 7 5
METOPROLOL SUCCINATE 208 195 8 10
HYDROCHLOROTHIAZIDE 208 201 8 9
HYDROCODONE-ACETAMINOPHEN 206 176 S3 10 7
WARFARIN SODIUM 191 164 11 8
ATORVASTATIN CALCIUM 176 131 12 15
METOPROLOL TARTRATE 171 165 13 14
LOSARTAN POTASSIUM 165 148 14 13
CITALOPRAM HBR 148 91 15 17
GABAPENTIN 147 126 16 18
TRIAMTERENE-HCTZ 132 126 17 26
METFORMIN HCL 128 108 18 11
PRAVASTATIN SODIUM 124 110 19 23
SPIRONOLACTONE 108 97 20 32
ZOLPIDEM TARTRATE 102 77 21 19
DIVALPROEX SODIUM 94 60 22 97
ALLOPURINOL 85 85 23 20
DIGOXIN 85 85 23 27
LOSARTAN-HYDROCHLOROTHIAZIDE 67 55 25 40
BENAZEPRIL HCL 65 55 26 46
FLUOXETINE HCL 64 33 27 31
TRIAMTERENE-HYDROCHLOROTHIAZID 64 61 27 91
FENTANYL 62 62 S2 29 43
QUINAPRIL HCL 62 62 29 155
ATENOLOL 61 59 31 16
ALENDRONATE SODIUM 60 51 32 22
CLONIDINE HCL 57 57 33 74
PAROXETINE HCL 55 55 34 45
PROPRANOLOL HCL 54 46 35 92
PREDNISONE 52 47 36 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.